Evidence map›Paper›PMID 33759542›Full record

SynthesisJournal of the American Heart Association2021

Fracture Risks in Patients Treated With Different Oral Anticoagulants: A Systematic Review and Meta-Analysis.

Huei-Kai Huang, Carol Chiung-Hui Peng, Shu-Man Lin, Kashif M Munir, Rachel Huai-En Chang, Brian Bo-Chang Wu, Peter Pin-Sung Liu, Jin-Yi Hsu, Ching-Hui Loh, Yu-Kang Tu

Open access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Journal of the American Heart Association, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Huei-Kai HuangInstitute of Epidemiology and Preventive Medicine College of Public Health National Taiwan University Taipei Taiwan.
Carol Chiung-Hui PengDepartment of Internal Medicine University of Maryland Medical Center Midtown Campus Baltimore MD.
Shu-Man LinDepartment of Physical Medicine and Rehabilitation Hualien Tzu Chi HospitalBuddhist Tzu Chi Medical Foundation Hualien Taiwan.
Kashif M MunirDivision of Endocrinology, Diabetes and Nutrition University of Maryland School of Medicine Baltimore MD.
Rachel Huai-En ChangThe Johns Hopkins University Bloomberg School of Public Health Baltimore MD.
Brian Bo-Chang WuSchool of Medicine College of Medicine Fu-Jen Catholic University New Taipei City Taiwan.
Peter Pin-Sung LiuCenter for Aging and Health Hualien Tzu Chi HospitalBuddhist Tzu Chi Medical Foundation Hualien Taiwan.
Jin-Yi HsuSchool of Medicine Tzu Chi University Hualien Taiwan.
Ching-Hui LohSchool of Medicine Tzu Chi University Hualien Taiwan.
Yu-Kang TuInstitute of Epidemiology and Preventive Medicine College of Public Health National Taiwan University Taipei Taiwan.
Tzu Chi University · TWNational Taiwan University · TWUniversity of Maryland, Baltimore · USFu Jen Catholic University · TWJohns Hopkins University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Evidence on the differences in fracture risk associated with non-vitamin K antagonist oral anticoagulants (NOAC) and warfarin is inconsistent and inconclusive. We conducted a systematic review and meta-analysis to assess the fracture risk associated with NOACs and warfarin. Methods and Results We searched PubMed, Embase, Cochrane Library, Scopus, Web of Science, and ClinicalTrials.gov from inception until May 19, 2020. We included studies presenting measurements (regardless of primary/secondary/tertiary/safety outcomes) for any fracture in both NOAC and warfarin users. Two or more reviewers independently screened relevant articles, extracted data, and performed quality assessments. Data were retrieved to synthesize the pooled relative risk (RR) of fractures associated with NOACs versus warfarin. Random-effects models were used for data synthesis. We included 29 studies (5 cohort studies and 24 randomized controlled trials) with 388 209 patients. Patients treated with NOACs had lower risks of fracture than those treated with warfarin (pooled RR, 0.84; 95% CI, 0.77-0.91;

Indexed as

Administration, OralAnticoagulantsAtrial FibrillationFractures, BoneGlobal HealthHumansIncidenceStrokeWarfarinAnticoagulantsWarfarinanticoagulantfracturemeta‐analysisNOACwarfarin

Identifiers

PMID33759542
PMCPMC8174313
OpenAlexW3138740258

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.